Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)

Clinical trial NCT02488993 · COMPLETED

Trial details

NCT number: NCT02488993
Sponsor: Norgine
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatic Encephalopathy

Start date: 2015-06-01
Primary completion: 2018-09-29
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.